Home › Funds › Bleichroeder LP › NMTC

Bleichroeder LP position in NMTC

NeuroOne Medical Technologies Corporat · Health Care

Bleichroeder LP reported holding 666,666 shares of NMTC (NeuroOne Medical Technologies Corporat) in its Q2 2026 13F filing — a position valued at US$2.0M, representing 0.36% of its reported portfolio and ranking #34 among its reported holdings. Bleichroeder LP has disclosed NMTC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)666.67K sh
Reported value held$2.03M
Portfolio Weight0.36%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bleichroeder LP's NMTC position evolved

Bleichroeder LP first disclosed a stake in NMTC in Q2 2025 at 4,000,000 shares (US$2.7M). The position peaked in Q3 2025 at 4,000,000 shares, worth US$3.6M. Across 5 filings, Bleichroeder LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 666,666 shares valued at US$2.0M — a reduction of -3,333,334 shares quarter over quarter.. Notable position changes include a 83% trim in Q2 2026 (shares fell 66% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 4.00M $2.71M New
Q3 2025 4.00M $3.55M Hold
Q4 2025 4.00M $3.03M Hold
Q1 2026 4.00M $3.11M Hold
Q2 2026 666.67K $2.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NMTC and 13F data

NMTC (NeuroOne Medical Technologies Corporat) is a Health Care company. 28 other funds we track also report a position in NMTC — the largest reported positions include PERKINS CAPITAL MANAGEMENT INC (US$744K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NMTC

All NMTC fund holders →

FAQ

How long has Bleichroeder LP held NMTC?

Bleichroeder LP has disclosed NMTC holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Bleichroeder LP's current position in NMTC?

As of Q2 2026, Bleichroeder LP holds 666.67K shares of NMTC (NeuroOne Medical Technologies Corporat), valued at $2.03M, representing 0.36% of its reported portfolio and ranking #34.

Has Bleichroeder LP been buying or selling NMTC?

In the latest 13F filing (Q2 2026), Bleichroeder LP reduced its position in NMTC. The position peaked in Q3 2025 at 4.00M shares.

Which other funds hold NMTC?

Other major institutional holders of NMTC include PERKINS CAPITAL MANAGEMENT INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.